Does anti-IL-5 deplete bronchial mucosal eosinophils in mild atopic asthma?

被引：0
作者：
Flood-Page, P
Menzies-Gow, A
Compton, C
Walls, C
Barnes, N
Robinson, DS
Kay, AB
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, NHLI Div, London, England
[2] GSK, Harlow, Essex, England
[3] London Chest Hosp, London E2 9JX, England
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2002年 / 109卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：743 / 743
页数：1
相关论文
共 50 条
  • [21] Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab
    Suzaki, Isao
    Kimura, Yurika
    Tanaka, Akihiko
    Hirano, Kojiro
    Ishibashi, Atsushi
    Mizuyoshi, Tomomi
    Ando, Izumi
    Kitajima, Tatsuya
    Watanabe, So
    Hinohira, Yasuyuki
    Kobayashi, Hitome
    AURIS NASUS LARYNX, 2019, 46 (01) : 141 - 146
  • [22] Anti-IL-5 and anti-IL-5R biologics for severe asthma. Are there any differences in their effects?
    Granda, Paula
    Villamanan, Elena
    Carpio, Carlos
    Laorden, Daniel
    Quirce, Santiago
    alvarez-Sala, Rodolfo
    JOURNAL OF ASTHMA, 2024, 61 (08) : 857 - 866
  • [23] Effectiveness of anti-IgE and anti-IL-5 treatment in step 5 asthma patients.
    Saji, Junko
    Muraoka, Hiromi
    Nishimoto, Eriko
    Matsuzawa, Shin
    Okamoto, Mariko
    Inoue, Teppei
    Handa, Hiroshi
    Nishine, Hiroki
    Inoue, Takeo
    Miyazawa, Teruomi
    Mineshita, Masamichi
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [24] Bronchodilator Responsiveness Does Not Help Determine Anti-IL-5 Targeted Biologic Success in Patients With Severe Asthma
    Zhao, Wei
    Hogan, Mary Beth
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (12) : 3184 - 3185
  • [25] Anti-IL-5 treatments in severe eosinophilic asthma: real life datas
    Ozdel Ozturk, Betul
    Bavbek, Sevim
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2020, 68 (02): : 148 - 159
  • [26] Anti-IL-5 biologics carve out severe-asthma niche
    Elie Dolgin
    Nature Biotechnology, 2014, 32 : 1075 - 1076
  • [27] Anti-IL-5 biologics carve out severe-asthma niche
    Dolgin, Elie
    NATURE BIOTECHNOLOGY, 2014, 32 (11) : 1075 - 1076
  • [28] Anti-IL-5 therapy and DRESS
    Khan, Sujoy
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (09) : 941 - 941
  • [29] A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma
    Busse, William W.
    Ring, Johannes
    Huss-Marp, Johannes
    Kahn, Jean-Emmanuel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (04) : 803 - 813
  • [30] Anti-IL-5 treatments are a useful adjunct for treatment of chronic severe asthma
    Nixon, Gillian M.
    McNamara, David G.
    Armstrong, David S.
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2024, 60 (10) : 613 - 615
12345